Acceleron Pharma Inc., a leading biopharmaceutical company headquartered in the United States, focuses on developing innovative therapies for rare diseases and serious health conditions. Founded in 2004, Acceleron has made significant strides in the industry, particularly in the fields of pulmonary and muscle-related disorders. The company is renowned for its unique approach to harnessing the power of the Transforming Growth Factor-beta (TGF-β) superfamily, which underpins its core products, including the groundbreaking treatment for pulmonary arterial hypertension. With a strong commitment to research and development, Acceleron has positioned itself as a key player in the biopharmaceutical landscape, achieving notable milestones that underscore its dedication to improving patient outcomes.
We don't have data for Acceleron Pharma Inc., but we can show you information about their parent organization instead.
View parent company